Company / Current Liabilities per Share
NEKTAR THERAPEUTICS Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$4.32
FY2025
5-year range
$0.27 / $4.32
FY2021-FY2025
Trend
+1247.4%
vs FY2024
Sector context
#43 of 210
Health Care
What the data says
Current Liabilities per Share changed +1247% YoY in FY2025, a notable deviation from the 9-year average annual change of +159%.
Based on SEC 10-K filings.
4.32 in FY2025 with a 5-year CAGR of +45.8%. Top quartile in the Health Care sector.
Increased from $0.27 to $4.32 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +127.4%
- 5-Year CAGR
- +45.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 210This company $4.32 Sector average $15.78
▼
-72.6% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 1247.4% year-over-year.
- Ranks #43 out of 210 companies in the Health Care sector.
- Lowest current liabilities per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -11.97 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.32 | +1247.4% |
| FY2024 | $0.32 | +18.0% |
| FY2023 | $0.27 | -26.1% |
| FY2022 | $0.37 | -22.3% |
| FY2021 | $0.47 | -27.9% |
| FY2020 | $0.66 | -67.8% |
| FY2019 | $2.04 | +296.7% |
| FY2018 | $0.51 | +40.2% |
| FY2017 | $0.37 | -31.3% |
| FY2016 | $0.53 | +14.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026